270 related articles for article (PubMed ID: 10468868)
1. Clonal immunoglobulin light chain variable region germline gene use in AL amyloidosis: association with dominant amyloid-related organ involvement and survival after stem cell transplantation.
Comenzo RL; Wally J; Kica G; Murray J; Ericsson T; Skinner M; Zhang Y
Br J Haematol; 1999 Sep; 106(3):744-51. PubMed ID: 10468868
[TBL] [Abstract][Full Text] [Related]
2. The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden.
Comenzo RL; Zhang Y; Martinez C; Osman K; Herrera GA
Blood; 2001 Aug; 98(3):714-20. PubMed ID: 11468171
[TBL] [Abstract][Full Text] [Related]
3. Analysis of V(lambda)-J(lambda) expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambdaIII) as a new amyloid-associated germline gene segment.
Perfetti V; Casarini S; Palladini G; Vignarelli MC; Klersy C; Diegoli M; Ascari E; Merlini G
Blood; 2002 Aug; 100(3):948-53. PubMed ID: 12130507
[TBL] [Abstract][Full Text] [Related]
4. Utility of Doppler myocardial imaging, cardiac biomarkers, and clonal immunoglobulin genes to assess left ventricular performance and stratify risk following peripheral blood stem cell transplantation in patients with systemic light chain amyloidosis (Al).
Bellavia D; Abraham RS; Pellikka PA; Dispenzieri A; Burnett JC; Al-Zahrani GB; Green TD; Manske MK; Gertz MA; Miller FA; Abraham TP
J Am Soc Echocardiogr; 2011 Apr; 24(4):444-54. PubMed ID: 21315556
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL).
Abraham RS; Geyer SM; Price-Troska TL; Allmer C; Kyle RA; Gertz MA; Fonseca R
Blood; 2003 May; 101(10):3801-8. PubMed ID: 12515719
[TBL] [Abstract][Full Text] [Related]
6. Systemic AL amyloidosis due to non-Hodgkin's lymphoma: an unusual clinicopathologic association.
Cohen AD; Zhou P; Xiao Q; Fleisher M; Kalakonda N; Akhurst T; Chitale DA; Moscowitz C; Dhodapkar MV; Teruya-Feldstein J; Filippa D; Comenzo RL
Br J Haematol; 2004 Feb; 124(3):309-14. PubMed ID: 14717777
[TBL] [Abstract][Full Text] [Related]
7. Identification of clonal immunoglobulin λ light-chain gene rearrangements in AL amyloidosis using next-generation sequencing.
Kimura K; Tsukamoto S; Miyazaki K; Kawajiri-Manako C; Ishii A; Rahmutulla B; Fukuyo M; Oshima-Hasegawa N; Mitsukawa S; Takeda Y; Mimura N; Takeuchi M; Ohwada C; Iseki T; Matsusaka K; Sanada M; Yokote K; Kaneda A; Ishida T; Suzuki K; Nakaseko C; Sakaida E
Exp Hematol; 2021 Sep; 101-102():34-41.e4. PubMed ID: 34411686
[TBL] [Abstract][Full Text] [Related]
8. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
[TBL] [Abstract][Full Text] [Related]
9. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients.
Comenzo RL; Vosburgh E; Falk RH; Sanchorawala V; Reisinger J; Dubrey S; Dember LM; Berk JL; Akpek G; LaValley M; O'hara C; Arkin CF; Wright DG; Skinner M
Blood; 1998 May; 91(10):3662-70. PubMed ID: 9573002
[TBL] [Abstract][Full Text] [Related]
10. The antisense approach in amyloid light chain amyloidosis: identification of monoclonal Ig and inhibition of its production by antisense oligonucleotides in in vitro and in vivo models.
Ohno S; Yoshimoto M; Honda S; Miyachi S; Ishida T; Itoh F; Endo T; Chiba S; Imai K
J Immunol; 2002 Oct; 169(7):4039-45. PubMed ID: 12244207
[TBL] [Abstract][Full Text] [Related]
11. Autologous stem cell transplantation for primary systemic amyloidosis.
Comenzo RL; Gertz MA
Blood; 2002 Jun; 99(12):4276-82. PubMed ID: 12036853
[TBL] [Abstract][Full Text] [Related]
12. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
13. Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.
Dispenzieri A; Seenithamby K; Lacy MQ; Kumar SK; Buadi FK; Hayman SR; Dingli D; Litzow MR; Gastineau DA; Inwards DJ; Micallef IN; Ansell SM; Johnston PB; Porrata LF; Patnaik MM; Hogan WJ; Gertz MA
Bone Marrow Transplant; 2013 Oct; 48(10):1302-7. PubMed ID: 23604010
[TBL] [Abstract][Full Text] [Related]
14. Evidence that amyloidogenic light chains undergo antigen-driven selection.
Perfetti V; Ubbiali P; Vignarelli MC; Diegoli M; Fasani R; Stoppini M; Lisa A; Mangione P; Obici L; Arbustini E; Merlini G
Blood; 1998 Apr; 91(8):2948-54. PubMed ID: 9531605
[TBL] [Abstract][Full Text] [Related]
15. Preferential expression of human lambda-light-chain variable-region subgroups in multiple myeloma, AL amyloidosis, and Waldenström's macroglobulinemia.
Ozaki S; Abe M; Wolfenbarger D; Weiss DT; Solomon A
Clin Immunol Immunopathol; 1994 May; 71(2):183-9. PubMed ID: 8181187
[TBL] [Abstract][Full Text] [Related]
16. Stability and aggregation propensity do not fully account for the association of various germline variable domain gene segments with light chain amyloidosis.
Garay Sánchez SA; Rodríguez Álvarez FJ; Zavala-Padilla G; Mejia-Cristobal LM; Cruz-Rangel A; Costas M; Fernández Velasco DA; Melendez-Zajgla J; Del Pozo-Yauner L
Biol Chem; 2017 Apr; 398(4):477-489. PubMed ID: 27935845
[TBL] [Abstract][Full Text] [Related]
17. Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation.
Sidiqi MH; Aljama MA; Muchtar E; Buadi FK; Warsame R; Lacy MQ; Dispenzieri A; Dingli D; Leung N; Gonsalves WI; Kumar SK; Kapoor P; Kourelis TV; Hogan WJ; Gertz MA
Blood Adv; 2018 Apr; 2(7):769-776. PubMed ID: 29615413
[TBL] [Abstract][Full Text] [Related]
18. Novel analysis of clonal diversification in blood B cell and bone marrow plasma cell clones in immunoglobulin light chain amyloidosis.
Abraham RS; Manske MK; Zuckerman NS; Sohni A; Edelman H; Shahaf G; Timm MM; Dispenzieri A; Gertz MA; Mehr R
J Clin Immunol; 2007 Jan; 27(1):69-87. PubMed ID: 17192818
[TBL] [Abstract][Full Text] [Related]
19. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
[TBL] [Abstract][Full Text] [Related]
20. Primary systemic amyloidosis.
Comenzo RL
Curr Treat Options Oncol; 2000 Apr; 1(1):83-9. PubMed ID: 12057064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
